
Please try another search
Sinphar Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally. It operates through three segments: Pharmaceuticals, Healthy Food, and Others. The company offers pharmaceutical products, including antineoplastic, ophthalmic, ENT, oral, respiratory system, dermatology, analgesic and NSAIDs, metabolic and nutrient, gastrointestinal, and other products; and healthy food under the Sinphar, DailyCare, Migus, YouBest, and SynCoreBio brands. It also provides moisturizer repair essence, anti aging cream, renewable oi, and UV defence cream under the DYNASKIN brand; serum, revitalizing cream, hygiene, sunblock, sunscreen, and lightening tables under the Yestuner brand; and shower gel and hair shampoo. In addition, the company is involved in the provision of testing and development, as well as product design and manufacturing services. The company was incorporated in 1977 and is based in Yilan City, Taiwan.
Name | Age | Since | Title |
---|---|---|---|
Hsiu-Ming Lin | - | - | Director |
King-Long Lee | - | - | Independent Director |
Hsiu-Chih Kuo | - | - | Director |
Zhiwen Li | - | 1977 | Founder & Chairman |
Hung Chih Lin | - | 2022 | Director |
Hsiu Min Lin | - | - | Director |
Hsiu Yu Chou | - | - | Independent Director |
Ching Lung Lee | - | - | Independent Director |
Ling Mo Chao | - | - | Director |
Hsiu Chi Kuo | - | - | Director |
Neng Chun Yu | - | 2022 | Director |
Yao Yuan Wen | - | - | Independent Director |
Yi-Ta Lee | 54 | - | Vice Chairman |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review